Has Russell Tobe, MD received payments from drug or device companies?

Yes. Drug and device makers reported $37,648 in general payments to Russell Tobe, MD across 41 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Russell Tobe, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Russell Tobe, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Russell Tobe, MD

Psychiatry · Orangeburg, NYNPI 1659539773

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Roche Products Limited at 36.6% of the total. Reporting peaked in 2019 at $32,061 and has fallen 95.0% since, to $1,590 in 2024. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,648in general payments, 2019–2025

Across 41 payments — averaging $918.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Roche Products Limited$14K
Genentech, Inc.$12K
Hoffmann-la Roche Limited$8K
F. Hoffmann-la Roche AG$5K

$1,589,682in research payments, 2019–2025

Across 145 payments — averaging $10,963 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Genentech, Inc.$585K
F. Hoffmann-la Roche AG$480K
Janssen Research & Development, LLC$389K
Hoffmann-la Roche Limited$100K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$35K

What the payments were for

Consulting fees$20,45054%
Travel & lodging$15,91142%
Food & beverage$1,2873%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Roche Products Limited	7	$13,781
Genentech, Inc.	16	$11,780
Hoffmann-la Roche Limited	14	$7,585
F. Hoffmann-la Roche AG	4	$4,502

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Non-Covered Product$29,005

How this compares

$37,648 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Medicare billing

Part B allowed, 2024

$59,240

Medicare patients

104

Services billed

421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Risperdal ConstaRisperidone Microspheres	11	$28,857
Risperidone ErRisperidone Microspheres	14	$25,082
Molindone Hcl	12	$15,956
Aripiprazole	179	$14,056
Divalproex Sodium	186	$10,992
Chlorpromazine Hcl	24	$6,571
Quetiapine Fumarate	226	$5,821
Fluvoxamine Maleate	125	$5,298
Olanzapine	190	$4,853
Risperidone	435	$4,241
Ziprasidone Hcl	92	$3,367
Doxepin Hcl	20	$3,303
Clozapine	63	$3,098
Divalproex Sodium ErDivalproex Sodium	71	$2,451
Propranolol Hcl	40	$2,160

Paid to pharmacies, not to this prescriber.

Other psychiatry in Orangeburg

Leslie CitromePomona$5.7M
Sanjay GuptaCheektowaga$1.9M
Richard PriceMonsey$1.7M
Adam AshtonAmherst$1.6M
Christoph CorrellGlen Oaks$1.5M
Manish ZinzuvadiaNew York$1.3M
George KruseBronx$1.2M
Jianping ChenNew York$1.2M
Horacio CapoteAmherst$1.1M
Yadagiri ChepuruYonkers$963K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →